May 1, 2026: Wegovy Competitor Completes Phase 3 in Trial of New GLP-1 Drug, as Wegovy Lawsuits Increase Some people who have taken Wegovy and other GLP-1s claim they suffered from unexpected gut problems, including bowel obstructions, gastroparesis, and pancreatic issues
Overall, our data highlight that the emergence of potential high replicators can correlate also with clinical parameters beyond the LTX context like HIV coinfection or HCC diagnosis as well as the genetic background of the IFNL4 gene
People with type 2 diabetes often deal with high blood sugar levels, and tirzepatide can help manage that
10.1111/epi.14591 5 ChopraA.KollaB
Small changes that are repeated daily change what the colon sees, shift microbial fermentation patterns, and over weeks to months can raise SCFA production and contribute to more consistent GLP-1 signaling
GLP-1 (glucagon-like peptide-1) is a hormone that is naturally secreted by specific cells in your gut shortly after you begin eating, typically within 10-15 minutes, with another peak 1-2 hours later (Huber et al 2024
